Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...

Shares of Mylan N.V. (NASDAQ: MYL) are soaring today, up 16.4% as of 11:40 a.m. EST, after the drugmaker reported better-than-expected Q3 earnings following the market close on Monday. Mylan announced ...

Shares of Mylan (NASDAQ: MYL) were sinking 11.4% as of 11:09 a.m. EST on Wednesday. The drugmaker reported its fourth-quarter results after the market closed on Tuesday. Unfortunately, there was very ...

Mylan is settling with the Securities and Exchange Commission for $30 million on charges it didn't disclose an EpiPen settlement loss in a timely manner. (Mylan) Mylan’s long-running EpiPen scandal ...

Mylan said last month it would restart production of hydroxychloroquine to meet global demand. (Mylan) Mylan is one of a group of drugmakers that have joined the global effort to supply doses of ...

Mylan, a company best known for generic drugs, watched its stock slide last year after it was named along with other generic-drug manufacturers in a case alleging price-fixing. The lawsuit, brought by ...

(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy ...

Mylan CEO Heather Bresch told CNBC that the pharmaceutical company's global supply chain experienced "minimal disruption" during the coronavirus pandemic. "As Covid hit different areas of the world at ...

A week after two more blood pressure drugs were recalled because they have a possible cancer-causing ingredient, the U.S. based Mylan Pharmaceuticals expanded its consumer-level voluntary nationwide ...